oky,

Nice to see GTCB finally go up after such a long decline. I guess the announcement they are cutting costs a bit helped as did the new cash from LFB. Unfortunately, it is far too little and is likely too late. The price for the cash was high in terms of dilution to shareholders. The cost cutting is long overdue, but they don't just need to focus on factor VIIa. The need to sell the rights to some of their other products, say factor X or one of the their CD20 MAbs for up front cash NOW, complete coverage of expenses in production/trials and a percentage of the future profits. Otherwise we are looking at another major dilution in 6 months or so. Who knows, maybe GTCB will do something to surprise me, which is why I only sold half my shares a while back.

Vinny

P.S. Nice to see the trolls staying away too.